Grosser Marianne, Luther Thomas, Fuessel Monika, Bickhardt Jakob, Magdolen Viktor, Baretton Gustavo
Institut für Pathologie, Technische Universität Dresden, D-01307 Dresden, Germany.
Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):66-74.
For sarcoidosis it is generally hypothesized that inherited factors and environmental antigens may contribute to pathogenesis. Since M. tuberculosis DNA was found in a significant percentage of sarcoidosis patients, we analyzed the relationship between HLA-DRB1 alleles, inflammatory markers and the presence of M. tuberculosis DNA in sarcoidosis and its influence on clinical course.
From 144 patients with sarcoidosis lung tissue, BAL and/or blood were investigated by means of PCR assays to detect an 123 bp multicopy element of M. tuberculosis DNA and HLA-DRB1 alleles, respectively. ACE was measured spectrophotometrically, sIL-2R by ELISA. Clinical data describing the disease course were available from 63 patients.
The percentage of M. tuberculosis positive sarcoidosis patients was significantly increased in the chronic patients group compared to acute disease. The percentage of HLA-DRB 103 positive patients was significantly higher in acute sarcoidosis, whereas in chronic disease the HLA-DRB111 positive patients were clearly over-represented. In addition, we found a highly significant correlation of HLA-DRB111 or -DRB115 alleles and/or the presence of M. tuberculosis DNA to a chronic disease course, whereas HLA-DRB103 or -DRB104 alleles combined with the absence of M. tuberculosis DNA were associated with an acute sarcoidosis (p = 0.009). ACE and sIL2-R serum levels were significantly higher in M. tuberculosis positive sarcoidosis independent of the HLA-DRB1 specificity, but did not differ between acute and chronic disease course alone.
The association between certain HLA-DR antigens, the presence of M. tuberculosis DNA and disease course indicates that specific antigens of M. tuberculosis may play a pathogenetic role in chronic sarcoidosis.
对于结节病,一般认为遗传因素和环境抗原可能参与其发病机制。由于在相当比例的结节病患者中发现了结核分枝杆菌DNA,我们分析了结节病患者中HLA - DRB1等位基因、炎症标志物与结核分枝杆菌DNA存在情况之间的关系及其对临床病程的影响。
对144例结节病患者的肺组织、支气管肺泡灌洗液(BAL)和/或血液分别进行聚合酶链反应(PCR)检测,以分别检测结核分枝杆菌DNA的一个123 bp多拷贝元件和HLA - DRB1等位基因。采用分光光度法测定血管紧张素转换酶(ACE),通过酶联免疫吸附测定法(ELISA)测定可溶性白细胞介素 - 2受体(sIL - 2R)。63例患者有描述疾病病程的临床资料。
与急性疾病相比,慢性患者组中结核分枝杆菌阳性的结节病患者百分比显著增加。急性结节病中HLA - DRB103阳性患者的百分比显著更高,而在慢性疾病中,HLA - DRB111阳性患者明显占优势。此外,我们发现HLA - DRB111或 - DRB115等位基因和/或结核分枝杆菌DNA的存在与慢性病程高度相关,而HLA - DRB103或 - DRB104等位基因与结核分枝杆菌DNA的缺失与急性结节病相关(p = 0.009)。无论HLA - DRB1特异性如何,结核分枝杆菌阳性的结节病患者中ACE和sIL - 2R血清水平均显著更高,但仅急性和慢性病程之间无差异。
特定的HLA - DR抗原、结核分枝杆菌DNA的存在与疾病病程之间的关联表明,结核分枝杆菌的特定抗原可能在慢性结节病中起致病作用。